I am worried that the Army's management of these programs and their associated industrial base.

I have pressed the Army to adequately fund these platforms, and we are here today looking at another inadequate budget request.

I worked to secure funding for the industrial base and workforce development programs that would support growing the skilled workforce.

I share the Air National Guard's concerns about the slow pace of fuel tanker recapitalization.

I remain troubled by the Army's lack of careful management of the industrial base, as I see it.

I am going to start where my vice chair left off by thanking and appreciating our incredible staff for the hard work and the long hours that they contributed to this product. Then I want to join my vice chair in appreciating the heroic…

over the last several days and weeks, I have heard a lot of discussion from some of my colleagues here in the Senate and in the House of Representatives about what they consider to be inappropriate congressionally directed spending…

I was pleased this last May that this Committee advanced my bipartisan Fair Drug Pricing Act, which I lead with Senator Braun.

The price of ELIQUIS is--in the U.S. has increased by $4,000 since its launch.

The price of ELIQUIS is--in the U.S. has increased by $4,000 since its launch.

The price of STELARA in the U.S. is $79,000 a year.

I think we need more transparency. And I think we need more transparency to inform the policies that we adopt.